-

Dr. Mita Manna Appointed Chair of REAL Canadian Breast Cancer Alliance, Advancing Research and Care for Breast Cancer Patients Nationwide

Saskatchewan Cancer Centre’s Dr. Mita Manna to Lead National Alliance, Drive Research and Advocate for Equitable Access to Innovative Treatments

TORONTO--(BUSINESS WIRE)--REAL Canadian Breast Cancer Alliance is pleased to announce the appointment of Dr. Mita Manna as the new Chair of the organization. Dr. Manna, a highly respected Hematologist and Medical Oncologist at the Saskatchewan Cancer Centre and soon-to-be Associate Professor at the University of Saskatchewan’s Department of Oncology (effective April 2025), brings a wealth of experience in breast cancer research, patient advocacy, and clinical leadership to this pivotal role.

Founded in 2023, REAL (Research Excellence and Active Leadership) Canadian Breast Cancer Alliance unites leading clinicians across Canada in a shared mission to advance breast cancer care through evidence-based research and to promote equity in access to cutting-edge treatments.

“I am deeply honoured to step into this leadership role and to build on the solid foundation established by Dr. Jan Willem Henning,” said Dr. Manna. “Dr. Henning’s visionary leadership has created an essential platform for collaboration among Canada’s top thought leaders in breast oncology. As Chair, I’m committed to ensuring that research continues to translate into accessible, life-saving care for patients nationwide.”

Dr. Jan Willem Henning, Immediate Past Chair & Founder of REAL Canadian Breast Cancer Alliance, expressed his confidence in Dr. Manna’s leadership. “Dr. Manna’s unwavering commitment to research, patient care, and advocacy will drive REAL’s future impact. Her leadership is vital to ensuring that all breast cancer patients in Canada benefit from the latest advancements in research.”

Kimberly Carson, CEO of Breast Cancer Canada, also welcomed Dr. Manna’s appointment: “Dr. Manna embodies an exceptional dedication to advancing research and improving patient outcomes. We are excited to work alongside her as we continue to strive for a future where every Canadian patient has access to the highest standard of breast cancer care.”

Under Dr. Manna’s leadership, REAL Canadian Breast Cancer Alliance will continue to champion innovative research, advocate for equitable access to the latest treatments, and foster collaboration among healthcare professionals, researchers, and patients to accelerate advancements in breast cancer care nationwide.

REAL Canadian Breast Cancer Alliance plays a key role in shaping national care standards, releasing annual clinical consensus recommendations that reflect the latest research outcomes and clinical trial data. These recommendations ensure comprehensive, evidence-based management for breast cancer patients.

The following national consensus recommendations are set to be completed and released later this year:

  • Treatment Management of HR+ Early Stage Breast Cancer
  • Treatment Management of HR+ Metastatic Breast Cancer
  • Treatment Management of Triple Negative Breast Cancer
  • Treatment Management Using Molecular Diagnostics and Markers

For more information on REAL Canadian Breast Cancer Alliance, its mission, and full membership, please visit realalliance.ca.

About REAL Canadian Breast Cancer Alliance

REAL Canadian Breast Cancer Alliance (established in December 2023) was formed to address critical gaps in breast cancer treatment and care. By bringing together leading experts in oncology from across Canada, REAL focuses on developing evidence-based clinical recommendations and advocating for updated, innovative treatment strategies. REAL’s national efforts are built on collaboration, involving recognized leaders from key Canadian cities including Calgary, Vancouver, Edmonton, Saskatoon, Toronto, Ottawa, Montreal, and St. John’s. For more information, please visit realalliance.ca.

About Breast Cancer Canada

Breast Cancer Canada is a national charity dedicated to saving lives through breast cancer research. With a focus on precision oncology, Breast Cancer Canada is the only national organization solely committed to funding research, advocating for progress, and educating the public on new scientific evidence. For more information, please visit breastcancerprogress.ca.

Contacts

Media
Hana Baig
Communications, Santis Health
Hana.baig@santishealth.ca

Breast Cancer Canada


Release Versions

Contacts

Media
Hana Baig
Communications, Santis Health
Hana.baig@santishealth.ca

More News From Breast Cancer Canada

Breast Cancer Canada launches MEGABike Campaign

TORONTO--(BUSINESS WIRE)--Breast Cancer Canada is proud to launch their national MEGABike campaign rolling into cities across the country in a high-impact fundraiser that drives critical research forward. Starting July 17 in London, Ontario and culminating September 29 in Victoria, British Columbia, MEGABike 2025 invites teams of up to 29 riders to power a 30-seat bike through city streets, raising funds and awareness for the most commonly diagnosed cancer in the world: breast cancer. “MEGABike...

Breast Cancer Canada Applauds Federal Commitment to Modernize Preventive Health Guidelines

TORONTO--(BUSINESS WIRE)--Breast Cancer Canada proudly celebrates the federal government’s response to the External Expert Review (EER) of the Canadian Task Force on Preventive Health Care, and the sweeping reforms it recommends to ensure preventive health guidance in Canada is more equitable, expert-informed, and responsive to real-world care. “These systematic changes will save lives,” said Kimberly Carson, CEO of Breast Cancer Canada. “We commend Canada’s Federal Health Minister Marjorie Mic...

Breast Cancer Canada Shares Major Announcements at ASCO 2025

TORONTO--(BUSINESS WIRE)--At the American Society of Clinical Oncology (ASCO) Annual Meeting, Breast Cancer Canada proudly announces a series of milestones and new initiatives driving patient-focused progress in breast cancer research and care across the country. These updates underscore the organization’s commitment to improving outcomes for every Canadian affected by breast cancer. Since 1991, Breast Cancer Canada has been laser focused on breast cancer research. Currently funding 26 labs acr...
Back to Newsroom